Werner Spengler

1.1k total citations
22 papers, 408 citations indexed

About

Werner Spengler is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Werner Spengler has authored 22 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Werner Spengler's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Werner Spengler is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Werner Spengler collaborates with scholars based in Germany, United Kingdom and Switzerland. Werner Spengler's co-authors include Marius Horger, Alexander Sauter, Christina Schraml, Anna C. Pfannenberg, Cornelia Brendle, Holger Schmidt, Nina F. Schwenzer, Claus D. Claussen, Mark Müller and Daniel Spira and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Werner Spengler

19 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Werner Spengler Germany	10	233	200	96	48	35	22	408
Yukihisa Tamaki Japan	11	177 0.8×	157 0.8×	67 0.7×	21 0.4×	21 0.6×	39	380
Michael A. Izard Australia	9	218 0.9×	106 0.5×	79 0.8×	30 0.6×	11 0.3×	19	354
Gem Kramer Netherlands	8	161 0.7×	194 1.0×	55 0.6×	21 0.4×	19 0.5×	14	287
Daniele Scartoni Italy	9	212 0.9×	110 0.6×	76 0.8×	48 1.0×	15 0.4×	45	351
Andrei Roman Romania	10	143 0.6×	68 0.3×	53 0.6×	21 0.4×	50 1.4×	33	320
Nina Jehanno France	9	93 0.4×	150 0.8×	55 0.6×	30 0.6×	12 0.3×	28	275
Yasuhiro Sasakawa Japan	11	164 0.7×	315 1.6×	132 1.4×	127 2.6×	21 0.6×	19	525
S. Fergus United States	5	214 0.9×	132 0.7×	139 1.4×	63 1.3×	13 0.4×	9	378
D. Francis United Kingdom	7	103 0.4×	288 1.4×	116 1.2×	63 1.3×	12 0.3×	10	422
Benedikt Gomez Germany	15	247 1.1×	517 2.6×	79 0.8×	11 0.2×	25 0.7×	23	650

Countries citing papers authored by Werner Spengler

Since Specialization

Citations

This map shows the geographic impact of Werner Spengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Spengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Spengler more than expected).

Fields of papers citing papers by Werner Spengler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Spengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Spengler. The network helps show where Werner Spengler may publish in the future.

Co-authorship network of co-authors of Werner Spengler

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Spengler. A scholar is included among the top collaborators of Werner Spengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Spengler. Werner Spengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

De‐Colle, Chiara, et al.. (2023). Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis. Strahlentherapie und Onkologie. 199(7). 668–675. 9 indexed citations

Spengler, Werner, Ferdinand Seith, Helmut Dittmann, et al.. (2023). Diagnostic Performance of Dynamic Whole-Body Patlak [18F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph Nodes. Journal of Clinical Medicine. 12(12). 3942–3942. 3 indexed citations

Häntschel, Maik, et al.. (2021). Influence of Pharyngeal Anaesthesia on Post-Bronchoscopic Coughing: A Prospective, Single Blinded, Multicentre Trial. Journal of Clinical Medicine. 10(20). 4773–4773.

Häntschel, Maik, Ralf Eberhardt, Christoph Petermann, et al.. (2021). Diagnostic Yield of Transbronchial Lung Cryobiopsy Compared to Transbronchial Forceps Biopsy in Patients with Sarcoidosis in a Prospective, Randomized, Multicentre Cross-Over Trial. Journal of Clinical Medicine. 10(23). 5686–5686. 7 indexed citations

Haentschel, Maik, Róbert Wágner, Werner Spengler, et al.. (2020). Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer. Lung Cancer. 141. 56–63. 17 indexed citations

Stratmann, Jan, Sebastian Michels, Daniel C. Christoph, et al.. (2018). Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 144(12). 2457–2463. 8 indexed citations

Syha, Roland, J. Hetzel, Werner Spengler, et al.. (2016). Bronchial Artery Embolization in Hemoptysis: 10-Year Survival and Recurrence-Free Survival in Benign and Malignant Etiologies – A Retrospective Study. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 188(11). 1061–1066. 26 indexed citations

Thaiss, Wolfgang, K Nikolaou, Werner Spengler, et al.. (2015). Imaging diagnosis in relapsing polychondritis and correlation with clinical and serological data. Skeletal Radiology. 45(3). 339–346. 26 indexed citations

Hetzel, Juergen, et al.. (2015). Incidental Lung Volume Reduction Following Fulminant Pulmonary Hemorrhage in a Patient with Severe Emphysema. Lung. 193(3). 429–432. 1 indexed citations

10.

Grosse, Ulrich, et al.. (2015). The middle lobe syndrome – Das Mittellappensyndrom (MLS). RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 187(11). 961–963.

11.

Ditt, Hendrik, et al.. (2015). Improved Detection of Bone Metastases from Lung Cancer in the Thoracic Cage using 5- and 1-mm Axial Images versus a New CT Software Generating Rib Unfolding Images. Academic Radiology. 22(4). 505–512. 18 indexed citations

12.

Eberhardt, Wilfried, Thomas Gauler, Christoph Pöttgen, et al.. (2014). Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE).. Journal of Clinical Oncology. 32(15_suppl). 7510–7510. 4 indexed citations

13.

Spira, Daniel, et al.. (2013). Assessment of Tumor Vascularity in Lung Cancer Using Volume Perfusion CT (VPCT) With Histopathologic Comparison. Journal of Computer Assisted Tomography. 37(1). 15–21. 50 indexed citations

14.

Spira, Daniel, et al.. (2013). Does volume perfusion computed tomography enable differentiation of metastatic and non-metastatic mediastinal lymph nodes in lung cancer patients? A feasibility study. Cancer Imaging. 13(3). 323–331. 6 indexed citations

15.

Faehling, Martin, et al.. (2013). EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case–control study of overall survival. Lung Cancer. 80(3). 306–312. 38 indexed citations

16.

Schwenzer, Nina F., Christina Schraml, Mark Müller, et al.. (2012). Pulmonary Lesion Assessment: Comparison of Whole-Body Hybrid MR/PET and PET/CT Imaging—Pilot Study. Radiology. 264(2). 551–558. 120 indexed citations

17.

Faehling, Martin, et al.. (2012). Treatment with EGFR tyrosine kinase inhibitors beyond progression in long-term responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival.. Journal of Clinical Oncology. 30(15_suppl). 7572–7572. 4 indexed citations

18.

Hehr, Thomas, Godehard Friedel, Volker Steger, et al.. (2009). Neoadjuvant Chemoradiation With Paclitaxel/Carboplatin for Selected Stage III Non–Small-Cell Lung Cancer: Long-Term Results of a Trimodality Phase II Protocol. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1376–1381. 9 indexed citations

19.

Thatcher, N., C. Kortsik, Werner Spengler, et al.. (2004). A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results. Journal of Clinical Oncology. 22(14_suppl). 7095–7095.

20.

Pilz, Lothar R., et al.. (2003). 774 Quality of life assessment and final results of a randomized Phase II study with single-agent gemcitabine and docetaxel given sequentially every 3 weeks show effective treatment in advanced NSCLC. European Journal of Cancer Supplements. 1(5). S233–S233. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact